Selected research
Market Structure
Global EMOCAP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global EMOCAP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of EMOCAP include StretchSense, Noitom, Vicon, Cyber Glove Systems, Rokoko, MANUS, AiQ Synertial, Virtual Motion Labs and PhaseSpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global EMOCAP market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of EMOCAP and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents EMOCAP revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the EMOCAP market size, projected growth trends, production technologies, key applications, and end-use industries.
EMOCAP Segment by Company
StretchSense
Noitom
Vicon
Cyber Glove Systems
Rokoko
MANUS
AiQ Synertial
Virtual Motion Labs
PhaseSpace
VRTRIX
HaptX
Virdyn
Qualisys AB
Xsens Technologyes
Optitrack
Codamotion
PTI Phoenix Technologies
Noraxon USA
NTT Data
EMOCAP Segment by Type
Whole Boby
Part Boby
EMOCAP Segment by Application
Scientific Research
Entertainment
Medical
Other
EMOCAP Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EMOCAP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EMOCAP and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EMOCAP.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of EMOCAP in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EMOCAP industry.
Chapter 3: Detailed analysis of EMOCAP companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EMOCAPrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Boby
- Part Boby
Applications
- Scientific Research
- Entertainment
- Medical
- Other
Companies covered
- StretchSense
- Noitom
- Vicon
- Cyber Glove Systems
- Rokoko
- MANUS
- AiQ Synertial
- Virtual Motion Labs
- PhaseSpace
- VRTRIX
- HaptX
- Virdyn
- Qualisys AB
- Xsens Technologyes
- Optitrack
- Codamotion
- PTI Phoenix Technologies
- Noraxon USA
- NTT Data
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global EMOCAP Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Whole Boby
- 1.2.3 Part Boby
- 1.3 Market Analysis by Application
- 1.3.1 Global EMOCAP Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Scientific Research
- 1.3.3 Entertainment
- 1.3.4 Medical
- 1.3.5 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global EMOCAP Growth Trends by Region
- 1.5.1 Global EMOCAP Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 EMOCAP Market Size by Region (2021-2026)
- 1.5.3 EMOCAP Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global EMOCAP Market Dynamics
- 2.1 EMOCAP Industry Trends
- 2.2 EMOCAP Industry Drivers
- 2.3 EMOCAP Industry Opportunities and Challenges
- 2.4 EMOCAP Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global EMOCAP Revenue by Company (2021-2026)
- 3.2 Global EMOCAP Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global EMOCAP Key Company Head office and Area Served
- 3.4 Global EMOCAP Company, Product Type & Application
- 3.5 Global EMOCAP Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global EMOCAP Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 EMOCAP Players Market Share by Revenue in 2025
- 3.6.3 2025 EMOCAP Tier 1, Tier 2, and Tier 3
4 EMOCAP Market by Type
- 4.1 Global EMOCAP Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global EMOCAP Market Size by Type (2021-2032)
- 4.3 Global EMOCAP Market Size Share by Type (2021-2032)
5 EMOCAP Market by Application
- 5.1 Global EMOCAP Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global EMOCAP Market Size by Application (2021-2032)
- 5.3 Global EMOCAP Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 StretchSense
- 6.1.1 StretchSense Company Information
- 6.1.2 StretchSense Business Overview
- 6.1.3 StretchSense EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 StretchSense EMOCAP Product Portfolio
- 6.1.5 StretchSense Recent Developments
- 6.2 Noitom
- 6.2.1 Noitom Company Information
- 6.2.2 Noitom Business Overview
- 6.2.3 Noitom EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Noitom EMOCAP Product Portfolio
- 6.2.5 Noitom Recent Developments
- 6.3 Vicon
- 6.3.1 Vicon Company Information
- 6.3.2 Vicon Business Overview
- 6.3.3 Vicon EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Vicon EMOCAP Product Portfolio
- 6.3.5 Vicon Recent Developments
- 6.4 Cyber Glove Systems
- 6.4.1 Cyber Glove Systems Company Information
- 6.4.2 Cyber Glove Systems Business Overview
- 6.4.3 Cyber Glove Systems EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Cyber Glove Systems EMOCAP Product Portfolio
- 6.4.5 Cyber Glove Systems Recent Developments
- 6.5 Rokoko
- 6.5.1 Rokoko Company Information
- 6.5.2 Rokoko Business Overview
- 6.5.3 Rokoko EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Rokoko EMOCAP Product Portfolio
- 6.5.5 Rokoko Recent Developments
- 6.6 MANUS
- 6.6.1 MANUS Company Information
- 6.6.2 MANUS Business Overview
- 6.6.3 MANUS EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 MANUS EMOCAP Product Portfolio
- 6.6.5 MANUS Recent Developments
- 6.7 AiQ Synertial
- 6.7.1 AiQ Synertial Company Information
- 6.7.2 AiQ Synertial Business Overview
- 6.7.3 AiQ Synertial EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 AiQ Synertial EMOCAP Product Portfolio
- 6.7.5 AiQ Synertial Recent Developments
- 6.8 Virtual Motion Labs
- 6.8.1 Virtual Motion Labs Company Information
- 6.8.2 Virtual Motion Labs Business Overview
- 6.8.3 Virtual Motion Labs EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Virtual Motion Labs EMOCAP Product Portfolio
- 6.8.5 Virtual Motion Labs Recent Developments
- 6.9 PhaseSpace
- 6.9.1 PhaseSpace Company Information
- 6.9.2 PhaseSpace Business Overview
- 6.9.3 PhaseSpace EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 PhaseSpace EMOCAP Product Portfolio
- 6.9.5 PhaseSpace Recent Developments
- 6.10 VRTRIX
- 6.10.1 VRTRIX Company Information
- 6.10.2 VRTRIX Business Overview
- 6.10.3 VRTRIX EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 VRTRIX EMOCAP Product Portfolio
- 6.10.5 VRTRIX Recent Developments
- 6.11 HaptX
- 6.11.1 HaptX Company Information
- 6.11.2 HaptX Business Overview
- 6.11.3 HaptX EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 HaptX EMOCAP Product Portfolio
- 6.11.5 HaptX Recent Developments
- 6.12 Virdyn
- 6.12.1 Virdyn Company Information
- 6.12.2 Virdyn Business Overview
- 6.12.3 Virdyn EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Virdyn EMOCAP Product Portfolio
- 6.12.5 Virdyn Recent Developments
- 6.13 Qualisys AB
- 6.13.1 Qualisys AB Company Information
- 6.13.2 Qualisys AB Business Overview
- 6.13.3 Qualisys AB EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Qualisys AB EMOCAP Product Portfolio
- 6.13.5 Qualisys AB Recent Developments
- 6.14 Xsens Technologyes
- 6.14.1 Xsens Technologyes Company Information
- 6.14.2 Xsens Technologyes Business Overview
- 6.14.3 Xsens Technologyes EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Xsens Technologyes EMOCAP Product Portfolio
- 6.14.5 Xsens Technologyes Recent Developments
- 6.15 Optitrack
- 6.15.1 Optitrack Company Information
- 6.15.2 Optitrack Business Overview
- 6.15.3 Optitrack EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Optitrack EMOCAP Product Portfolio
- 6.15.5 Optitrack Recent Developments
- 6.16 Codamotion
- 6.16.1 Codamotion Company Information
- 6.16.2 Codamotion Business Overview
- 6.16.3 Codamotion EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Codamotion EMOCAP Product Portfolio
- 6.16.5 Codamotion Recent Developments
- 6.17 PTI Phoenix Technologies
- 6.17.1 PTI Phoenix Technologies Company Information
- 6.17.2 PTI Phoenix Technologies Business Overview
- 6.17.3 PTI Phoenix Technologies EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 PTI Phoenix Technologies EMOCAP Product Portfolio
- 6.17.5 PTI Phoenix Technologies Recent Developments
- 6.18 Noraxon USA
- 6.18.1 Noraxon USA Company Information
- 6.18.2 Noraxon USA Business Overview
- 6.18.3 Noraxon USA EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Noraxon USA EMOCAP Product Portfolio
- 6.18.5 Noraxon USA Recent Developments
- 6.19 NTT Data
- 6.19.1 NTT Data Company Information
- 6.19.2 NTT Data Business Overview
- 6.19.3 NTT Data EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 NTT Data EMOCAP Product Portfolio
- 6.19.5 NTT Data Recent Developments
7 North America
- 7.1 North America EMOCAP Market Size (2021-2032)
- 7.2 North America EMOCAP Market Size by Type
- 7.2.1 North America EMOCAP Market Size by Type (2021-2026)
- 7.2.2 North America EMOCAP Market Size by Type (2027-2032)
- 7.2.3 North America EMOCAP Market Share by Type (2021-2032)
- 7.3 North America EMOCAP Market Size by Application
- 7.3.1 North America EMOCAP Market Size by Application (2021-2026)
- 7.3.2 North America EMOCAP Market Size by Application (2027-2032)
- 7.3.3 North America EMOCAP Market Share by Application (2021-2032)
- 7.4 North America EMOCAP Market Size by Country
- 7.4.1 North America EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America EMOCAP Market Size by Country (2021-2026)
- 7.4.3 North America EMOCAP Market Size by Country (2027-2032)
- 7.4.4 North America EMOCAP Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe EMOCAP Market Size (2021-2032)
- 8.2 Europe EMOCAP Market Size by Type
- 8.2.1 Europe EMOCAP Market Size by Type (2021-2026)
- 8.2.2 Europe EMOCAP Market Size by Type (2027-2032)
- 8.2.3 Europe EMOCAP Market Share by Type (2021-2032)
- 8.3 Europe EMOCAP Market Size by Application
- 8.3.1 Europe EMOCAP Market Size by Application (2021-2026)
- 8.3.2 Europe EMOCAP Market Size by Application (2027-2032)
- 8.3.3 Europe EMOCAP Market Share by Application (2021-2032)
- 8.4 Europe EMOCAP Market Size by Country
- 8.4.1 Europe EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe EMOCAP Market Size by Country (2021-2026)
- 8.4.3 Europe EMOCAP Market Size by Country (2027-2032)
- 8.4.4 Europe EMOCAP Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China EMOCAP Market Size (2021-2032)
- 9.2 China EMOCAP Market Size by Type
- 9.2.1 China EMOCAP Market Size by Type (2021-2026)
- 9.2.2 China EMOCAP Market Size by Type (2027-2032)
- 9.2.3 China EMOCAP Market Share by Type (2021-2032)
- 9.3 China EMOCAP Market Size by Application
- 9.3.1 China EMOCAP Market Size by Application (2021-2026)
- 9.3.2 China EMOCAP Market Size by Application (2027-2032)
- 9.3.3 China EMOCAP Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia EMOCAP Market Size (2021-2032)
- 10.2 Asia EMOCAP Market Size by Type
- 10.2.1 Asia EMOCAP Market Size by Type (2021-2026)
- 10.2.2 Asia EMOCAP Market Size by Type (2027-2032)
- 10.2.3 Asia EMOCAP Market Share by Type (2021-2032)
- 10.3 Asia EMOCAP Market Size by Application
- 10.3.1 Asia EMOCAP Market Size by Application (2021-2026)
- 10.3.2 Asia EMOCAP Market Size by Application (2027-2032)
- 10.3.3 Asia EMOCAP Market Share by Application (2021-2032)
- 10.4 Asia EMOCAP Market Size by Country
- 10.4.1 Asia EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia EMOCAP Market Size by Country (2021-2026)
- 10.4.3 Asia EMOCAP Market Size by Country (2027-2032)
- 10.4.4 Asia EMOCAP Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa EMOCAP Market Size (2021-2032)
- 11.2 South America, Middle East & Africa EMOCAP Market Size by Type
- 11.2.1 South America, Middle East & Africa EMOCAP Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa EMOCAP Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa EMOCAP Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa EMOCAP Market Size by Application
- 11.3.1 South America, Middle East & Africa EMOCAP Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa EMOCAP Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa EMOCAP Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa EMOCAP Market Size by Country
- 11.4.1 South America, Middle East & Africa EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa EMOCAP Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa EMOCAP Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa EMOCAP Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst